RIVASTIGMINE TARTRATE
Generic: RIVASTIGMINE TARTRATE
Dr. Reddy's Laboratories LimitedManufacturer
ORALRoute
RIVASTIGMINE TARTRATEActive Substance
2007-10-31Original Approval
RIVASTIGMINE TARTRATE is FDA application ANDA077130, sponsored by DR REDDYS LABS INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class III2017-03-06
RIVASTIGMINE Tartrate Capsules, USP, 1.5 mg, 60-count bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, BachupCross-contamination with other products -Related Substances test for Rivastigmine Tartrate Capsules
Class II2015-08-03
Rivastigmine Tartrate Capsules, USP 1.5 mg, 60 count bottle, Rx Only, Mfd. By Dr. Reddy's Laboratories Limited, BachupalFailed Dissolution Specifications
Top Reported Reactions
1
HALLUCINATION
912 reports
2
FALL
858 reports
3
DEATH
689 reports
4
CONFUSIONAL STATE
626 reports
5
DRUG INEFFECTIVE
593 reports
6
PARKINSON^S DISEASE
406 reports
7
FATIGUE
394 reports
8
CONDITION AGGRAVATED
386 reports
9
GAIT DISTURBANCE
385 reports
10
OFF LABEL USE
376 reports